Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

unknown120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

NCT02890589
completednot_applicable

MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial

NCT03135275
completednot_applicable

ENdothelial Healing Assessment With Novel Coronary tEchnology

NCT02747199
unknownnot_applicable

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII

NCT02093845
completednot_applicable

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

NCT02881216

Clinical Trials (5)

Showing 5 of 5 trials
NCT02890589Not Applicable

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

Completed
NCT03135275Not Applicable

MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial

Completed
NCT02747199Not Applicable

ENdothelial Healing Assessment With Novel Coronary tEchnology

Completed
NCT02093845Not Applicable

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII

Unknown
NCT02881216Not Applicable

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5